ESLA Estrella Immunopharma Inc reports wider than expected Q1 2026 EPS loss but shares rise 13 percent in regular trading EVV Eaton Vance Limited Duration Income Fund posts 285 percent year over year Q1 2025 revenue drop shares rise 011 percent Why investors are rethinking Starz STRZ Drifts Lower 20260508 John Wiley WLYB Stock Is It Testing Levels John Wiley and Sons posts 117 pct EPS beat on strong academic demand